Genelux Stock (NASDAQ: GNLX) stock price, news, charts, stock research, profile.
Open | $3.190 |
Close | - |
Volume / Avg. | 90.052K / 139.226K |
Day Range | 3.060 - 3.190 |
52 Wk Range | 3.070 - 40.980 |
Market Cap | $87.044M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 8.73% |
Days to Cover | 27.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genelux (NASDAQ: GNLX) through any online brokerage.
Other companies in Genelux’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), Curis (NASDAQ:CRIS), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for Genelux (NASDAQ: GNLX) was reported by Benchmark on Wednesday, April 3, 2024. The analyst firm set a price target for 30.00 expecting GNLX to rise to within 12 months (a possible 861.54% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Genelux (NASDAQ: GNLX) is $3.12 last updated Today at April 30, 2024 at 3:57 PM EDT.
There are no upcoming dividends for Genelux.
Genelux’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Genelux.
Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.